Zobrazeno 1 - 10
of 114
pro vyhledávání: '"R. N. Alyautdin"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 2, Pp 190-200 (2024)
INTRODUCTION. Osteoporosis is a leading cause of morbidity, disability, reduced quality of life, and premature mortality in the elderly population. Denosumab is a treatment for osteoporosis; however, denosumab discontinuation may cause a rebound effe
Externí odkaz:
https://doaj.org/article/fdbf7028a4be4045bb00a1d7a5195737
Autor:
A. A. Nekipelova, R. N. Alyautdin
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 3, Pp 279-291 (2023)
Scientific relevance. Cardiovascular diseases (CVD) are the leading cause of death worldwide. Dyslipidemia, as the pathophysiological basis of atherosclerosis, is the most important cause of CVD. Among the factors that modify this pathology, the Worl
Externí odkaz:
https://doaj.org/article/37dc74137031498e8a42b654d2f1b2ec
Autor:
E. A. Sokova, V. V. Arkhipov, A. S. Kazakov, B. K. Romanov, R. N. Alyautdin, M. V. Zhuravleva
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 2, Pp 110-117 (2022)
Aztreonam is the only approved monocyclic β-lactam antibiotic for human use that is active against Gram-negative aerobes, primarily Pseudomonas аeruginosa. Aztreonam has been used for more than 35 years, and aztreonam lysine has been on the market
Externí odkaz:
https://doaj.org/article/a77fbae6300d4640a1140181d0a07218
Publikováno v:
Ведомости Научного центра экспертизы средств медицинского применения, Vol 12, Iss 2, Pp 173-182 (2022)
To ensure the safety of herbal medicinal products, particularly in liquid dosage forms, it is necessary to control environmental toxins to acceptable levels. However, there is no methodology for individual elemental impurities in tinctures. The aim o
Externí odkaz:
https://doaj.org/article/49f292b67e4a425eb4f306cf0d62fe6b
Autor:
R. N. Alyautdin, B. K. Romanov, В. К. Лепахин, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 2, Pp 10-16 (2022)
Paclitaxel is an effective antitumor agent used for treatment of breast cancer, lung, stomach and pancreas. However, its own adverse effects and the use of toxic Cremophor EL as the solvent limit the application range of this drug. Associated with th
Externí odkaz:
https://doaj.org/article/0790c234e1d34de89f348153b91c9c46
Autor:
R. N. Alyautdin R.N, B. K. Romanov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 3, Pp 5-10 (2022)
The article presents the history of the exploration of arrow poisons, used in Asia, Africa and South America. The active ingredients of these poisonswere widely used and continue to apply currently in traditional and official medicine. Methodology fo
Externí odkaz:
https://doaj.org/article/2f8ccb8c4cfc4e0896f3e96fa09e0e87
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 3, Pp 15-19 (2022)
In this article authors analyze the influence of a label on drugpackage on the risk of medication errors and propose methods of their prevention.Analysis of the corresponding data published by regulators EMA and FDA hasprovided an opportunity to find
Externí odkaz:
https://doaj.org/article/6e264189c4e248cdabd5e43f72569274
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 2, Pp 5-9 (2022)
Acetaminophen is one of the most commonly used analgesics /anti pyretics. However, taking into account the existing risk of hepatotoxicity,regulatory bodies of a number of the countries made additional adjustments tothe recommendations on the use of
Externí odkaz:
https://doaj.org/article/d1847d9742e64d49a9ae412f2d58e9a2
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 4, Pp 12-17 (2022)
This review presents information on pharmaceuticals that have the properties of inverse agonists. The article describes the features of the interaction of the ligand - receptor with constitutive conformational changes. Many of ligands, assumed to be
Externí odkaz:
https://doaj.org/article/c8b4f228118f4873b99ffe97c17632ac
Autor:
R. N. Alyautdin, B. K. Romanov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 4, Pp 6-11 (2022)
This review presents information on pharmaceuticals that have the properties of inverse agonists. The article describes the features of the interaction of the ligand - receptor with constitutive conformational changes. Many of ligands, assumed to be
Externí odkaz:
https://doaj.org/article/8dda3d9359cc4b578a6f80c5f3c0c323